Showing 1151-1160 of 2676 results for "".
Surgical Management of Intractable Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/surgical-management-of-intractable-epilepsy/30178/Neurosurgical techniques are effective and underutilized for patients with drug-resistant epilepsy.Neuromodulation and Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/neuromodulation-and-epilepsy/30179/From the vagal nerve to the deep brain, neuromodulation provides another treatment option for patients with epilepsy.Dizziness and Vertigo
https://practicalneurology.com/diseases-diagnoses/headache-pain/dizziness-and-vertigo/30119/Part 1: Untangling the complexity of dizziness and vertigo requires a careful history.Intracranial Atherosclerotic Disease
https://practicalneurology.com/diseases-diagnoses/stroke/intracranial-atherosclerotic-disease/30143/Neurologists need to be vigilant for this common cause of ischemic stroke, associated with the highest rates of recurrent stroke.Healthy Cognitive Aging
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/healthy-cognitive-aging/30159/There are evidence-based tools for staying sharp throughout the lifespan.Blood-Based Biomarkers in Alzheimer Disease: Clinical Implementation and Limitations
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/blood-based-biomarkers-in-alzheimer-disease-clinical-implementation-and-limitations/32100/Although biomarkers for Alzheimer disease have the potential to improve evaluation and care, barriers to implementation remain.Dietary Treatments for Patients with Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/dietary-treatments-for-patients-with-epilepsy/30181/Ketogenic diets are an effective treatment when used properly with medical supervision and support.Helmets, Sensors, and More: A Review
https://practicalneurology.com/diseases-diagnoses/child-neurology/helmets-sensors-and-more-a-review/30572/From football to bicycle, helmets provide defense against traumatic brain injuries. How good are they?- In Memoriam: Ralph L. Sacco, MD, MS, FAHA, FAANhttps://practicalneurology.com/news/in-memoriam-ralph-l-sacco-md-ms-faha-faan/2470102/
- FDA Clears L-4-Chlorokynurenine for Phase 2 Trials in Levodopa-Induced Dyskinesiahttps://practicalneurology.com/news/fda-clears-l-4-chlorokynurenine-for-phase-2-trials-in-levodopa-induced-dyskinesia/2469143/The Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for L-4-chlorokynurenine (AV-101, VistaGen Therapeutics, South San Francisco, CA), as a potential treatment for levodopa-induced dyskinesia. The FDA's IND clearance permits the procession of the p